Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial

S. Masiero, SJ. Connolly, D. Birnie, J. Neuzner, SH. Hohnloser, X. Vinolas, J. Kautzner, G. O'Hara, L. VanErven, F. Gadler, J. Wang, P. Mabo, M. Glikson, V. Kutyifa, DJ. Wright, V. Essebag, JS. Healey, . ,

. 2017 ; 19 (6) : 1002-1006.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18034115

Aims: Pocket haematoma is a common complication after defibrillator [implantable cardioverter defibrillator (ICD)] implantation, which is not only painful, but also increases the risk of device-related infection, and possibly embolic events. The present study seeks to evaluate the rate and predictors of clinically significant pocket haematoma. Methods and results: This study included 2500 patients receiving an ICD in the SIMPLE trial. A clinically significant pocket haematoma was defined as a haematoma that required re-operation or interruption of oral anticoagulation (OAC) therapy. Clinically significant pocket haematoma occurred in 56 of 2500 patients (2.2%) of which 6 (10.7%) developed device-related infection. Patients who developed pocket haematoma were older (mean age 67.6 ± 8.8 years vs. 62.7 ± 11.6 years, P < 0.001), were more likely to have permanent atrial fibrillation (30.4 vs. 6.7%, P < 0.001) and a history of stroke (17.9 vs. 6.7%, P = 0.004), or were more likely to receive peri-operative OAC (50.0 vs. 28.4%, P < 0.001), unfractionated heparin (16.1 vs. 5.2%, P = 0.003), or low-molecular-weight heparin (37.5 vs. 17.5%, P < 0.001). Independent predictors of wound haematoma on multivariable analysis included the use of heparin bridging (OR 2.65, 95% CI 1.48-4.73, P = 0.001), sub-pectoral location of ICD (OR 2.00, 95% CI 1.12-3.57, P =0.020), previous stroke (OR 2.47, 95% CI 1.20-5.10, P = 0.015), an upgrade from permanent pacemaker (OR 2.52, 95% CI 1.07-5.94, P = 0.035), and older age (OR 1.03, 95% CI 1.00-1.06, P = 0.049). Conclusion: Pocket haematoma remains an important complication of ICD implantation and is associated with a high risk of infection. Independent predictors of pocket haematoma include heparin bridging, prior stroke, sub-pectoral placement of ICD, older age, and upgrade from a pacemaker.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18034115
003      
CZ-PrNML
005      
20181026115843.0
007      
ta
008      
181008s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euw116 $2 doi
035    __
$a (PubMed)27353323
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Masiero, Simona $u Population Health Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON, Canada L8L 2X2. Clinica di Cardiologia, Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy.
245    10
$a Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial / $c S. Masiero, SJ. Connolly, D. Birnie, J. Neuzner, SH. Hohnloser, X. Vinolas, J. Kautzner, G. O'Hara, L. VanErven, F. Gadler, J. Wang, P. Mabo, M. Glikson, V. Kutyifa, DJ. Wright, V. Essebag, JS. Healey, . ,
520    9_
$a Aims: Pocket haematoma is a common complication after defibrillator [implantable cardioverter defibrillator (ICD)] implantation, which is not only painful, but also increases the risk of device-related infection, and possibly embolic events. The present study seeks to evaluate the rate and predictors of clinically significant pocket haematoma. Methods and results: This study included 2500 patients receiving an ICD in the SIMPLE trial. A clinically significant pocket haematoma was defined as a haematoma that required re-operation or interruption of oral anticoagulation (OAC) therapy. Clinically significant pocket haematoma occurred in 56 of 2500 patients (2.2%) of which 6 (10.7%) developed device-related infection. Patients who developed pocket haematoma were older (mean age 67.6 ± 8.8 years vs. 62.7 ± 11.6 years, P < 0.001), were more likely to have permanent atrial fibrillation (30.4 vs. 6.7%, P < 0.001) and a history of stroke (17.9 vs. 6.7%, P = 0.004), or were more likely to receive peri-operative OAC (50.0 vs. 28.4%, P < 0.001), unfractionated heparin (16.1 vs. 5.2%, P = 0.003), or low-molecular-weight heparin (37.5 vs. 17.5%, P < 0.001). Independent predictors of wound haematoma on multivariable analysis included the use of heparin bridging (OR 2.65, 95% CI 1.48-4.73, P = 0.001), sub-pectoral location of ICD (OR 2.00, 95% CI 1.12-3.57, P =0.020), previous stroke (OR 2.47, 95% CI 1.20-5.10, P = 0.015), an upgrade from permanent pacemaker (OR 2.52, 95% CI 1.07-5.94, P = 0.035), and older age (OR 1.03, 95% CI 1.00-1.06, P = 0.049). Conclusion: Pocket haematoma remains an important complication of ICD implantation and is associated with a high risk of infection. Independent predictors of pocket haematoma include heparin bridging, prior stroke, sub-pectoral placement of ICD, older age, and upgrade from a pacemaker.
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a srdeční arytmie $x diagnóza $x mortalita $x terapie $7 D001145
650    _2
$a rozdělení chí kvadrát $7 D016009
650    12
$a defibrilátory implantabilní $x škodlivé účinky $7 D017147
650    _2
$a elektrická defibrilace $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D004554
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hematom $x diagnóza $x epidemiologie $7 D006406
650    _2
$a heparin $x aplikace a dávkování $x škodlivé účinky $7 D006493
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a nelineární dynamika $7 D017711
650    _2
$a odds ratio $7 D016017
650    _2
$a prospektivní studie $7 D011446
650    _2
$a implantace protézy $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D019919
650    _2
$a infekce spojené s protézou $x epidemiologie $7 D016459
650    _2
$a rizikové faktory $7 D012307
650    _2
$a chirurgická rána $x diagnóza $x epidemiologie $7 D000072836
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Connolly, Stuart J $u Population Health Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON, CanadaL8L 2X2.
700    1_
$a Birnie, David $u University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, CanadaK1Y 4W7.
700    1_
$a Neuzner, Jörg $u Klinikum Kassel, 43, Mönchebergstraße 41, 34125 Kassel, Germany.
700    1_
$a Hohnloser, Stefan H $u J.W. Goethe University, Theodor-W.-Adorno-Platz 6, 60323 Frankfurt am Main, Germany.
700    1_
$a Vinolas, Xavier $u Hospital de Santa Creu i Sant Pau, Carrer de Sant Quintí 89, 08026 Barcelona, Spain.
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Vídenská 1958/9, 140 21 Prague 4-Krc, Czech Republic.
700    1_
$a O'Hara, Gilles $u Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Ch Ste-Foy, Québec, QC, CanadaG1V 4G5.
700    1_
$a VanErven, Lieselot $u Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
700    1_
$a Gadler, Fredrik $u Karolinska Institute, Solnavägen 1, 171 77 Stockholm, Sweden.
700    1_
$a Wang, Jia $u Population Health Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON, CanadaL8L 2X2.
700    1_
$a Mabo, Philippe $u Centre Hospitalier Universitaire, 2 Rue Henri le Guilloux, 35000 Rennes, France.
700    1_
$a Glikson, Michael $u Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, 52621 Tel Aviv, Israel.
700    1_
$a Kutyifa, Valentina $u University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA.
700    1_
$a Wright, David J $u Institute of Cardiovascular Medicine and Science Liverpool Heart and Chest Hospital, Thomas Dr, Liverpool, Merseyside L14 3PE, UK.
700    1_
$a Essebag, Vidal $u McGill University, 845 Rue Sherbrooke O, Montrèal, QC, CanadaH3A 0G4.
700    1_
$a Healey, Jeff S $u Population Health Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON, CanadaL8L 2X2.
700    1_
$a ,
773    0_
$w MED00149837 $t Europace European pacing, arrhythmias, and cardiac electrophysiology journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 19, č. 6 (2017), s. 1002-1006
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27353323 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181026120354 $b ABA008
999    __
$a ok $b bmc $g 1340447 $s 1031109
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 19 $c 6 $d 1002-1006 $i 1532-2092 $m Europace $n Europace $x MED00149837
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Možnosti archivace